Director's Dealings

RNS Number : 3008K

Nanoco Group PLC

26 July 2013

 



For immediate release

26 July 2013

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

Director's Dealings

Nanoco Group plc (AIM: NANO) announces that on 25 July 2013, sole legal title in respect of 929,162 ordinary shares of 10 pence each in the Company ("Ordinary Shares") was transferred to Michael Edelman from the Nanoco Employee Benefit Trust (the "EBT"). Previously these Ordinary Shares were jointly owned by Michael Edelman and the EBT.

Therefore, Michael Edelman's total interest in the Company remains unchanged. Dr. Edelman owns 6,988,640 Ordinary Shares, equivalent to 3.3% of the Company's issued share capital.

For further information:

Nanoco	+ 44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
Colin White, Chief Financial Officer
Canaccord Genuity - Nomad and Joint Broker	[phone]
Simon Bridges
Cameron Duncan
Liberum Capital - Joint Broker	+ 44 (0) 20 3100 2000
Simon Atkinson
Richard Bootle
Buchanan	+ 44 (0) 20 7466 5000
Mark Court / Fiona Henson / Sophie Cowles

Notes for editors:

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots for use in multiple applications including LCD displays, lighting and solar cells. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and business development offices in the USA, Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

END

 

 

RDSQQLFLXDFFBBX